262 related articles for article (PubMed ID: 15866336)
1. Novel sustained release microspheres for pulmonary drug delivery.
Cook RO; Pannu RK; Kellaway IW
J Control Release; 2005 May; 104(1):79-90. PubMed ID: 15866336
[TBL] [Abstract][Full Text] [Related]
2. Effervescent dry powder for respiratory drug delivery.
Ely L; Roa W; Finlay WH; Löbenberg R
Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987
[TBL] [Abstract][Full Text] [Related]
3. Microencapsulated chitosan nanoparticles for lung protein delivery.
Grenha A; Seijo B; Remuñán-López C
Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
[TBL] [Abstract][Full Text] [Related]
4. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
[TBL] [Abstract][Full Text] [Related]
6. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs.
Fiegel J; Fu J; Hanes J
J Control Release; 2004 May; 96(3):411-23. PubMed ID: 15120898
[TBL] [Abstract][Full Text] [Related]
7. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
Thi TH; Danède F; Descamps M; Flament MP
Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
[TBL] [Abstract][Full Text] [Related]
8. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.
Learoyd TP; Burrows JL; French E; Seville PC
Eur J Pharm Biopharm; 2008 Feb; 68(2):224-34. PubMed ID: 17560772
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
[TBL] [Abstract][Full Text] [Related]
11. Poly(glycerol adipate-co-ω-pentadecalactone) spray-dried microparticles as sustained release carriers for pulmonary delivery.
Tawfeek H; Khidr S; Samy E; Ahmed S; Murphy M; Mohammed A; Shabir A; Hutcheon G; Saleem I
Pharm Res; 2011 Sep; 28(9):2086-97. PubMed ID: 21533998
[TBL] [Abstract][Full Text] [Related]
12. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
[TBL] [Abstract][Full Text] [Related]
13. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
14. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
15. Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery.
Ni R; Zhao J; Liu Q; Liang Z; Muenster U; Mao S
Eur J Pharm Sci; 2017 Mar; 99():137-146. PubMed ID: 27988327
[TBL] [Abstract][Full Text] [Related]
16. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.
Nasr M; Awad GA; Mansour S; Taha I; Al Shamy A; Mortada ND
Eur J Pharm Biopharm; 2011 Nov; 79(3):601-11. PubMed ID: 21827854
[TBL] [Abstract][Full Text] [Related]
17. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
Hadinoto K; Zhu K; Tan RB
Int J Pharm; 2007 Aug; 341(1-2):195-206. PubMed ID: 17467934
[TBL] [Abstract][Full Text] [Related]
18. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
Minne A; Boireau H; Horta MJ; Vanbever R
Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
[TBL] [Abstract][Full Text] [Related]
20. Sustained delivery by leucine-modified chitosan spray-dried respirable powders.
Learoyd TP; Burrows JL; French E; Seville PC
Int J Pharm; 2009 May; 372(1-2):97-104. PubMed ID: 19429272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
